Tag: pancreatic
Stress Checks
Breakthrough pancreatic cancer drug doubles survival in late-stage patients
FDA-approved daraxonrasib may double survival for late-stage pancreatic cancer patients after chemotherapy failure, per University of Chicago trial data.
Stress Checks
FDA approves first-of-its-kind therapy for metastatic pancreatic cancer
FDA approves Rasonque, a first-in-class therapy for metastatic pancreatic cancer. Learn about this new targeted treatment.